Delivery Order SPE2DX22D0010-SPE2D826FCE24
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Amphetamine Mix (AD) Extended Release capsules in 20 mg dosage. This competitively awarded, non-set-aside delivery order carries a firm fixed price ceiling value of $1,214.30, with an ultimate completion date of November 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a ceiling value of $1,055.37 and an ultimate completion date of October 1, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 10mg, with a contract ceiling value of $2,071.44 and a completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules, 25mg, with a ceiling value of $4,993.24. This is a firm fixed price delivery order awarded on November 6, 2025, with an ultimate completion date of November 7, 2025. The contract employs no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,866.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25mg. The contract was executed on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This was a competitive award with no set-aside designation. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,459.67 and is scheduled for completion by December 19, 2025. The contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract has a ceiling value of $2,643.72 with a firm fixed price structure and an ultimate completion date of December 22, 2025. The pharmaceutical products will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg with a ceiling value of $4,271.13. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. No set-aside designation was applied to this competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $2,137.71. This competitively awarded, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitive delivery order, valued at $2,555.08 with firm fixed pricing, will be completed by December 31, 2025, and represents a continuation of the government's pharmaceutical procurement efforts through established contract vehicles. The award carries no set-aside designation,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCE24Delivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Amphetamine Mix (AD) Extended Release capsules at 20mg dosage. This is a firm fixed price delivery order with a ceiling value of $3,202.54 and an ultimate completion date of January 6, 2026. The contract was competitively awarded with no set-aside designation, and performance will be executed from the company's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains, serving customers including the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 1/4/26 |